Cargando…

Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients

BACKGROUND & AIMS: To determine the prognostic potential of classic and novel serologic antibodies regarding unfavorable disease course in a prospective ulcerative colitis (UC) patient cohort, since few and conflicting data are available in the literature regarding this matter. METHODS: 187 cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovacs, Gyorgy, Sipeki, Nora, Suga, Boglarka, Tornai, Tamas, Fechner, Kai, Norman, Gary L., Shums, Zakera, Antal-Szalmas, Peter, Papp, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874003/ https://www.ncbi.nlm.nih.gov/pubmed/29590158 http://dx.doi.org/10.1371/journal.pone.0194166

Ejemplares similares

Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study
por: Tornai, David, et al.
Publicado: (2021)

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis
por: Tornai, Tamas, et al.
Publicado: (2018)

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis
por: Tornai, Tamas, et al.
Publicado: (2017)

Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
por: Gatselis, Nikolaos K, et al.
Publicado: (2020)

Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis
por: Papp, Maria, et al.
Publicado: (2016)

Presence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?
por: Papp, Maria, et al.
Publicado: (2010)

Serological biomarkers for management of primary sclerosing cholangitis
por: Tornai, David, et al.
Publicado: (2022)

TRAF1 Gene Polymorphism Correlates with the Titre of Gp210 Antibody in Patients with Primary Biliary Cirrhosis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2012)

Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort
por: Mullen, Michael T., et al.
Publicado: (2012)

Discrete terminal ileal ulcers in patients diagnosed with ulcerative colitis: clinical significance and natural course
por: Lim, Hyo-Jin, et al.
Publicado: (2021)

A novel splice site indel alteration in the EIF2AK3 gene is responsible for the first cases of Wolcott-Rallison syndrome in Hungary
por: Sümegi, Andrea, et al.
Publicado: (2020)

The dual role of Escherichia coli in the course of ulcerative colitis
por: Pilarczyk-Zurek, Magdalena, et al.
Publicado: (2016)

Serological Biomarker-Based Machine Learning Models for Predicting the Relapse of Ulcerative Colitis
por: Pang, Wenwen, et al.
Publicado: (2023)

Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis
por: Wunsch, Ewa, et al.
Publicado: (2020)

The Value of Neutrophil-to-Lymphocyte Ratio to Identify Bacterial Infection and Predict Short-Term Mortality in Patients with Acutely Decompensated Cirrhosis
por: Janka, Tamás, et al.
Publicado: (2023)

Is the Long-term Disease Course of Elderly-Onset Ulcerative Colitis Different from That of Non-Elderly-Onset Ulcerative Colitis?
por: Lee, Jin Wook, et al.
Publicado: (2021)

Effects of Appendectomy on the Onset and Course of Ulcerative Colitis in Chinese Patients
por: Chen, Dafan, et al.
Publicado: (2018)

Correlation between Histological Activity and Endoscopic, Clinical, and Serologic Activities in Patients with Ulcerative Colitis
por: Kim, Dae Bum, et al.
Publicado: (2016)

Disease Activity Is Associated with Obesity in Newly Diagnosed Pediatric Patients with Ulcerative Colitis
por: Kadenczki, Orsolya, et al.
Publicado: (2022)

Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis
por: Narang, Vikram, et al.
Publicado: (2018)

Clinical course of ulcerative colitis patients who develop acute pancreatitis
por: Kim, Jong Wook, et al.
Publicado: (2017)

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
por: Viscido, Angelo, et al.
Publicado: (2019)

Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis
por: Nishihara, Yuichiro, et al.
Publicado: (2021)

Association between Takayasu arteritis and ulcerative colitis – case report and review of serological HLA analysis
por: Takahashi, Nobuyuki, et al.
Publicado: (2011)

Serological profiling of Crohn’s disease and ulcerative colitis patients reveals anti-microbial antibody signatures
por: Shome, Mahasish, et al.
Publicado: (2022)

Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme
por: Winthrop, Kevin L, et al.
Publicado: (2020)

Coordinated action of human papillomavirus type 16 E6 and E7 oncoproteins on competitive endogenous RNA (ceRNA) network members in primary human keratinocytes
por: László, Brigitta, et al.
Publicado: (2021)

Markers of inflammation and influence of nitric oxide on platelet activation in the course of ulcerative colitis
por: Gawrońska, Beata, et al.
Publicado: (2017)

ABCC7/CFTR Expression Is Associated with the Clinical Course of Ulcerative Colitis Patients
por: Villeda-Ramírez, Marco A., et al.
Publicado: (2021)

The Diagnostic Value of Anti-Parietal Cell and Intrinsic Factor Antibodies, Pepsinogens, and Gastrin-17 in Corpus-Restricted Atrophic Gastritis
por: Kriķe, Petra, et al.
Publicado: (2022)

ULCERATIVE COLITIS
Publicado: (1969)

Reliability of the Endoscopic Ultrasound Ulcerative Colitis (EUS-UC) score for assessment of inflammation in patients with ulcerative colitis
por: Yan, Brian M., et al.
Publicado: (2021)

Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program
por: Sands, Bruce E, et al.
Publicado: (2021)

Identification of Immunoglobulin G Autoantibody Against Malondialdehyde-Acetaldehyde Adducts as a Novel Serological Biomarker for Ulcerative Colitis
por: Duryee, Michael J., et al.
Publicado: (2022)

Acute Pancreatitis due to pH-Dependent Mesalazine That Occurred in the Course of Ulcerative Colitis
por: Arai, Yoshinori, et al.
Publicado: (2011)

Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies
por: Monstad, Iril, et al.
Publicado: (2014)

Histopathologic Parameters at Diagnosis as Early Predictors of Histologic Remission along the Course of Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2020)

Microbiological Profile of Adenoid Hypertrophy Correlates to Clinical Diagnosis in Children
por: Szalmás, Anita, et al.
Publicado: (2013)

Plasma microRNA Profile Differentiates Crohn’s Colitis From Ulcerative Colitis
por: Netz, Uri, et al.
Publicado: (2018)

Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis
por: Lichtenstein, Gary R.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u7c2pbc9huk9im3umrv803qjv9